Evolv's Record Quarter Grew 10% — and 20% at the Same Time
A deliberate pricing rework moved revenue off the income statement and into ARR. Management spent the call explaining why that's good. The stock, down 25% in 90 days, isn't convinced yet.
EVLV · Earnings Call · 2026-11-10
Two Growth Rates, One Business
Evolv Technologies reported record third-quarter revenue of $47.3 million, up 10% year over year. That is the headline number. Management then spent the better part of an hour explaining why it is the wrong number to look at. The mechanism is simple and self-inflicted. Over the last 18 months Evolv cut the upfront hardware price and raised software and services by the same amount, leaving total contract value untouched. Economically nothing changed. Accounting-wise, a meaningful slice of each contract migrated out of onetime product revenue and into recurring revenue recognized across a four-year contract term. CFO Chris Kutsor put it plainly: “The economics have not changed, but the revenue mix has, which we believe is better for the long term value of the business” — George Chris Kutsor, Chief Financial Officer · 2026-11-10. The keyword record confirms how completely this bridge consumed the quarter. Evolv's freshly curated top five themes are onetime product revenue, operating plan, upfront product revenue, pricing change and contract term. When a revenue-recognition translation table becomes the dominant vocabulary of a quarterly call, that itself is the story: the business is performing; the income statement is being rebuilt in real time. Strip out the largest contract in company history (which sat in the year-ago quarter) and the pricing shift, and growth was 18% to 19%. ARR rose 20% to $141 million. RPO rose 12% to $326 million, or more than 1.7x the full-year revenue outlook. Net revenue retention held at 108%.Promise Kept — and Still Punished
The most interesting thing about this print is that it is the delivery of a promise made in August. On that call, Jeremy Hamblin pressed on the gap between unit growth and ARR growth, and Kutsor answered: “We do expect ARR growth to continue to accelerate from here as we have talked about compared to the past” — George Chris Kutsor, Chief Financial Officer · 2026-08-11. Three months later ARR growth is running at double the rate of reported revenue. Hamblin came back this quarter, skeptical: “you have been at kind of the steady ARR growth rate now for the last 3 quarters of around 20%. Can you just walk us through that acceleration?” — Jeremy Hamblin, Analyst · 2026-11-10 It was a fair challenge, and it was answered — with a slide deck. The equity did not care. EVLV has fallen roughly 25% over the last 90 trading days and sits 26% below its early-August high of $6.13, a drawdown that has compressed the sales multiple to 6.1x revenue, down 30% year over year and left the shares down more than half from their 2021 peak. Revenue kept compounding — the last filed quarter showed $44 million, up 34% year over year — but the multiple gave it all back. This quarter's 10% headline is precisely the kind of print a de-rated stock cannot afford.What Management Stopped Talking About
Contrast is more revealing than consensus here. Three themes that carried earlier calls have simply vanished from the keyword record. The World Cup was a headline talking point in August, when John Kedzierski described supporting “an international event of that scale” — John Kedzierski, President and Chief Officer · 2026-08-11. This quarter: not mentioned. The Plexus manufacturing migration, narrated for three straight quarters as a margin and working-capital tailwind, is absent. And the Gen 1-to-Gen 2 upgrade cycle — the '60% of renewing customers upgraded' statistic that drove the second-quarter narrative — has dropped out of the top tiers entirely, replaced by a quieter alert rate and red box product story around eXpedite 3.0. Even 'sales cycle,' the number-one keyword last quarter, is gone. What replaced them is forward-looking and investment-flavored: operating plan, repeated insistently because it is not yet finalized, and new sellers — a sales-capacity build that management concedes takes several quarters to become productive.The 2027 Air Pocket, and the Latent Lever
Guidance is where the tension lives. Full-year 2026 revenue was tightened to $182–185 million, growth of 25% to 27%. The initial 2027 view is 20% or more — a step down, and one that already absorbs a 3% to 4% self-inflicted pricing headwind. Management was explicit that the first half faces brutal comparisons and that “ARR growth to outpace revenue in 2027” — John Kedzierski, President and CEO · 2026-11-10. More units will ship in 2027 than 2026, but the incremental ones land in the back half, limiting in-year recurring revenue. It is a deliberate air pocket, funded by gross profit and a balance sheet carrying $33 million of effective net cash alongside positive free cash flow. The real latent lever sits in the backlog. Embedded in that $326 million of RPO is a gross margin of roughly 66%, against a current 50.2% gross margin. Kutsor flagged it as the earnings engine of the model:Contracted revenue converting at 66 points, versus a reported 50, is the quietest bull case on the call. One detail worth flagging: the two executives attached different magnitudes to the identical illustrative $70,000 contract — $4,200 from the CFO, $8,000 from the CEO. It may be cumulative-versus-incremental framing, but on a call devoted to explaining accounting precision, the imprecision stood out.Important element of our path to higher profitability is gross margin profile embedded in our remaining performance obligation, which we estimate to be approximately 66% gross margin. Well above our current reported gross margin levels.